Reversible cognitive disorders after sunitinib for advanced renal cell cancer in patients with preexisting arteriosclerotic leukoencephalopathy. [electronic resource]
- Annals of oncology : official journal of the European Society for Medical Oncology Oct 2007
- 1747-50 p. digital
Publication Type: Case Reports; Letter
1569-8041
10.1093/annonc/mdm455 doi
Aged Aged, 80 and over Antineoplastic Agents--adverse effects Carcinoma, Renal Cell--drug therapy Cognition Disorders--chemically induced Dementia, Vascular--complications Female Humans Indoles--adverse effects Kidney Neoplasms--drug therapy Male Pyrroles--adverse effects Sunitinib